This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,067.19 firm fixed-price delivery order contract is for the provision of 30-count packages of 4 mg Ondansetron orally-disintegrating tablets. The contract has an ultimate completion date of November 5, 2024 and was awarded on November 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. None of the contract awards reviewed were designated with specific set-aside requirements, indicating open competition.
Generated 2/3/25, 1:21 PM